Assignee
AlzeCure Pharma AB
SE·3 granted patents·5 pending applications·3 citations·filing 2017–2024
Top patents by PatentIndex Score
8 records- 0183US12209071B2Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2022·Granted Jan 28, 2025·1 cites·32 claims
- 0279US11352332B2Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2019·Granted Jun 7, 2022·1 cites·2 claims
- 0374US2025214948A1Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2024·Application pending·0 cites
- 0468US11840524B24-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptorsAlzeCure Pharma AB·Filed 2019·Granted Dec 12, 2023·1 cites·33 claims
- 0544US2024216338A1New formulations and usesAlzeCure Pharma AB·Filed 2022·Application pending·0 cites
- 0643US2022324819A1Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2020·Application pending·0 cites
- 0737US2020113910A1Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinasesAlzeCure Pharma AB·Filed 2017·Application pending·0 cites
- 0837US2021261513A14-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptorsAlzeCure Pharma AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AlzeCure Pharma AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →